Ennaid Therapeutics advances work on Zika virus in wake of crisis

Privately-held Georgia, USA-based Ennaid Therapeutics, says it is developing therapeutic cures to help the millions of people worldwide when infected with the mosquito-borne disease, Zika Virus, now named a global public health emergency by the World Health Organization and the Centers for Disease Prevention and Control (CDC).

The global health community is urging caution and care in response to Zika's explosive spread and is calling for rapidly stepped up efforts by researchers to find therapeutics and vaccines for those who contract it.

For years, Ennaid Therapeutics has been committed to developing cures for mosquito-borne diseases, including Dengue, Chikungunya and Zika viruses – and is now advancing its work on Zika to address the urgent global need.